GSK PLC (GSK)
42.57
+1.13
(+2.73%)
USD |
NYSE |
May 01, 16:00
42.51
-0.06
(-0.14%)
Pre-Market: 06:18
GSK Gross Profit Margin (Quarterly): 69.97% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 69.97% |
| September 30, 2023 | 72.11% |
| June 30, 2023 | 73.08% |
| March 31, 2023 | 72.05% |
| December 31, 2022 | 69.66% |
| September 30, 2022 | 69.05% |
| June 30, 2022 | 68.60% |
| March 31, 2022 | 62.21% |
| December 31, 2021 | 60.64% |
| September 30, 2021 | 69.58% |
| June 30, 2021 | 70.74% |
| March 31, 2021 | 66.57% |
| December 31, 2020 | 39.96% |
| September 30, 2020 | 66.63% |
| June 30, 2020 | 67.88% |
| March 31, 2020 | 64.81% |
| December 31, 2019 | 63.50% |
| September 30, 2019 | 65.42% |
| June 30, 2019 | 66.23% |
| March 31, 2019 | 64.33% |
| December 31, 2018 | 64.57% |
| September 30, 2018 | 67.42% |
| June 30, 2018 | 68.40% |
| March 31, 2018 | 66.89% |
| December 31, 2017 | 66.51% |
| Date | Value |
|---|---|
| September 30, 2017 | 66.19% |
| June 30, 2017 | 64.22% |
| March 31, 2017 | 65.97% |
| December 31, 2016 | 66.94% |
| September 30, 2016 | 66.52% |
| June 30, 2016 | 67.48% |
| March 31, 2016 | 65.76% |
| December 31, 2015 | 59.58% |
| September 30, 2015 | 64.03% |
| June 30, 2015 | 65.95% |
| March 31, 2015 | 62.59% |
| December 31, 2014 | 67.20% |
| September 30, 2014 | 67.61% |
| June 30, 2014 | 69.03% |
| March 31, 2014 | 68.95% |
| December 31, 2013 | 63.42% |
| September 30, 2013 | 67.57% |
| June 30, 2013 | 70.20% |
| March 31, 2013 | 69.46% |
| December 31, 2012 | 70.33% |
| September 30, 2012 | 67.99% |
| June 30, 2012 | 69.05% |
| March 31, 2012 | 72.62% |
| December 31, 2011 | 72.07% |
| September 30, 2011 | 70.68% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
39.96%
Minimum
Dec 2020
73.08%
Maximum
Jun 2023
66.25%
Average
67.88%
Median
Jun 2020
Gross Profit Margin (Quarterly) Benchmarks
| AstraZeneca PLC | 82.51% |
| Novo Nordisk A/S | 84.80% |
| Pfizer Inc | 46.92% |
| Sanofi SA | 69.07% |
| Moderna Inc | 66.97% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 41.85% |
| Return on Assets | 8.29% |
| Return on Invested Capital | 15.54% |
| Profit Margin (Quarterly) | 4.35% |
| Operating Margin (Quarterly) | 14.57% |
| Return on Net Operating Assets | 11.15% |